Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. TRML
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
TRML
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

TRML Similar Chart Price Prediction

The price of TRML is predicted to go up -26.67%, based on the high correlation periods with GRYP. The similarity of these two price pattern on the periods is 98.84%.

stocks logo

TRML

stocks logo

GRYP

Down: -26.67%Similarity: 98.84%

TRML Revenue Forecast

TRML EPS Forecast

TRML FAQs

What is bull’s view on TRML?

Tourmaline Bio (TRML) has a bullish outlook with a price target of $49, supported by H.C. Wainwright and BMO Capital analysts. The optimism stems from the promising potential of its lead asset, pacibekitug, in treating ASCVD, with significant Phase 2 trial results expected by mid-2025. Current analyst ratings and genetic validation for IL-6 inhibition further strengthen the stock's growth potential.

What is bear's view on TRML?

TRML stock currently has a bullish outlook from analysts, with a price target of $49, reflecting strong confidence in its lead asset pacibekitug and ongoing Phase 2 TRANQUILITY trial results expected by mid-2025. However, the stock's recent price of $24.38 (as of December 2024) suggests limited short-term upside unless new catalysts emerge. Bearish sentiment may focus on valuation concerns or delays in clinical milestones.

What is TRML eps forecast for next quarter？

The market consensus for TRML's eps in the upcoming quarter is projected to be approximately $0.87 USD.

TRML VS S&P500

Ask Intellectia about TRML

TRML Analyst's Forecast

Jimmy Shan

LifeSci Capital

Buy

2025-02-24

Price Target

$58

Upside

+373.47%

LifeSci Capital initiated coverage of Tourmaline Bio with an Outperform rating and $58 price target.
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free

Hot Stocks

stocks logo

RXO

RXO Inc

$19.93
1.42%
stocks logo

ASB

Associated Banc-Corp

$24.19
0.12%
stocks logo

ACHC

Acadia Healthcare Company Inc

$42.35
4.13%
stocks logo

KMPR

Kemper Corp

$65.77
1.09%
stocks logo

ORA

Ormat Technologies Inc

$68.51
-0.17%
stocks logo

VRRM

Verra Mobility Corp

$26.16
1.24%
stocks logo

OGN

Organon & Co

$16.13
6.96%
stocks logo

CORZ

Core Scientific Inc

$9.76
-1.01%
stocks logo

IBOC

International Bancshares Corp

$65.57
1.42%
stocks logo

CRGY

Crescent Energy Co

$13.69
-3.59%